α1-Adrenoceptors And At1 Receptors In

The Modulation Of Renal

Hemodynamics In High Salt And Doca

Models Of Hypertensive Rats Treated

With Tempol And Losartan by Yen,  Pei Pei
α1-ADRENOCEPTORS AND AT1 RECEPTORS IN 
THE MODULATION OF RENAL 
HEMODYNAMICS IN HIGH SALT AND DOCA 
MODELS OF HYPERTENSIVE RATS TREATED 
WITH TEMPOL AND LOSARTAN 
 
 
 
by 
 
 
 
YEN PEI PEI 
 
 
 
Thesis submitted in fulfillment of the requirements 
for the degree of 
Master of Science 
 
 
May 2016 
ii 
ACKNOWLEDGEMENT 
 
I praise to The Almighty God for granting me strength and patience to 
complete this research. I would like to express my sincere appreciation and gratitude 
to the following persons for their support during the research. To my supervisor, Prof. 
Dr. Munavvar Zubaid bin Abdul Sattar, thanks for your guidance, encouragement, 
advice, help and valuable suggestion in the research. To my co-supervisor, Dr. 
Hassaan Anwer Rathore, thanks for guiding and helping me when needed. To my 
field supervisor, Associate Prof. Dr. Nor Azizan Abdullah, University Malaya, 
thanks for your advice and knowledge of this field. Many thanks to Professor 
Emeritus Dr. Edward Jones, University College Cork, Ireland, for his advice and 
comment throughout this study. Not forgetting my lab mates and staffs of the School 
of Pharmaceutical Sciences for their kind support and help throughout the 
completion of this research. Special thanks to Mybrain Scheme from Malaysian 
government for supporting me by paying tuition fees for a year during my study. I 
wish to express my gratitude to the institute of postgraduate studies (IPS) for 
supporting me with financial aid to work as graduate assistant in USM as well as 
giving me the research grant. Lastly, I would like to extend my sincere thanks and 
gratitude to my family members and friends for their love, support, prayer, and 
encouragement. 
 
 
 
 
  
 iii 
 
TABLE OF CONTENTS 
 
Page 
Acknowledgement                                                                                                               ii 
Table of Contents                                                                                                                iii 
List of Tables                                                                                                                    viii 
List of Figures                                                                                                                     ix 
List of Abbreviations                                                                                                         xv 
Abstrak                                                                                                                             xvii 
Abstract                                                                                                                             xix 
  
CHAPTER 1: INTRODUCTION 1 
1.1 Urinary system 3 
1.1.1 Kidney 3 
1.1.2 Nephron 6 
1.1.2 (a) Renal corpuscle and glomerulus 8 
1.1.2 (b) Proximal tubule 9 
1.1.2 (c) Loop of Henle 10 
1.1.2 (d) Distal tubule and collecting duct 11 
1.2 Blood vessels 14 
1.3 Heart  15 
1.4 Adrenergic receptors 17 
1.4.1 Classification of adrenergic receptors 17 
1.4.2 Renal α-adrenergic mechanism 18 
1.5 Hypertension 19 
1.5.1 Definition 19 
1.5.2 Types of hypertension 20 
1.5.3 Renin-angiotensin-aldosterone system 21 
1.5.4 Sympathetic nervous system 22 
1.6 Oxidative stress 24 
1.6.1 Free radicals 25 
1.6.2 Reactive oxygen species 26 
1.6.3 Reactive nitrogen species 27 
1.6.4 Antioxidants 27 
1.7 Tempol  28 
1.8 Losartan  30 
 iv 
 
1.9 Objectives of study 32 
 
CHAPTER 2: METHODOLOGY 33 
2.1 Experimental animals 33 
2.2 Protocol of study 36 
2.3 Preparation of deoxycorticosterone-salt hypertensive rats 37 
2.4 Measurement of conscious or non invasive blood pressure 38 
2.5 Collection of metabolic data 38 
2.6 Acute experiment 39 
2.6.1 Haemodynamic study: Surgical preparations 39 
2.6.2 Determination of mean arterial pressure and renal cortical blood flow basal 
values 41 
2.6.3 Acute renal vasoconstrictor responses experimental protocol 42 
2.6.4 Termination of the experiment 42 
2.7 Measurement of pulse wave velocity 43 
2.8 Measurement of plasma and urinary creatinine level 44 
2.9 Calculation of renal functional parameters 45 
2.9.1 Urine flow rate 45 
2.9.2 Absolute creatinine clearance (ml/min) 46 
2.9.3 Creatinine clearance ml/min/100 gram of body weight 46 
2.9.4 Absolute Na
+
 or K
+
 excretion (mmol/hour/100 gram of body weight) 47 
2.9.5 Fractional Na
+
 or K
+
 excretion FE Y (%) 47 
2.9.6 Urinary sodium to Urinary potassium ratio 48 
2.9.7 Kidney index 48 
2.10 Preparation of drugs 49 
2.11 Statistical analysis 49 
2.12 Chemicals and instruments 50 
 
CHAPTER 3: RESULTS   53 
3.1 Results of SD rat with normal diet control (SD-N-C), tempol treated SD rat with 
normal diet (SD-N-T), losartan treated SD rat with normal diet (SD-N-L) and tempol 
& losartan treated SD rat with normal diet (SD-N-TL) groups 53 
3.1.1 Body weight 53 
3.1.2 Water intake 54 
3.1.3 Urine flow rate and urine output 54 
3.1.4 Mean arterial blood pressure, systolic blood pressure, diastolic blood 
pressure and heart rate 55 
3.1.5 Plasma creatinine, urine creatinine and creatinine clearance 56 
 v 
 
3.1.6 Plasma & urinary sodium and potassium 57 
3.1.7 Absolute and fractional sodium excretion 58 
3.1.8 Urinary sodium potassium ratio 58 
3.1.9 Pulse wave velocity and baseline renal cortical blood perfusion 59 
3.1.10 Renal Vasoconstrictor responses 59 
3.1.10 (a) Noradrenaline 59 
3.1.10 (b) Phenylephrine 60 
3.1.10 (c) Methoxamine 60 
3.1.10 (d) Angiotensin II 61 
3.2 Results of SD rat with normal diet control (SD-N-C), SD rat with sodium diet 
control (SD-S-C), tempol treated SD rat with sodium diet (SD-S-T), losartan treated 
SD rat with sodium diet (SD-S-L) and tempol & losartan treated SD rat with sodium 
diet (SD-S-TL) groups 62 
3.2.1 Body weight 62 
3.2.2 Water intake 63 
3.2.3 Urine flow rate and urine output 64 
3.2.4 Mean arterial blood pressure, systolic blood pressure, diastolic blood 
pressure and heart rate 66 
3.2.5 Plasma creatinine, urine creatinine and creatinine clearance 68 
3.2.6 Plasma & urinary sodium and potassium 70 
3.2.7 Absolute sodium excretion and fractional sodium excretion 72 
3.2.8 Urinary sodium to potassium ratio 74 
3.2.9 Pulse wave velocity and baseline renal cortical blood perfusion 75 
3.2.10 Renal Vasoconstrictor responses 75 
3.2.10 (a) Noradrenaline 75 
3.2.10 (b) Phenylephrine 76 
3.2.10 (c) Methoxamine 77 
3.2.10 (d) Angiotensin II 78 
3.3 Results of SD rat with normal diet control (SD-N-C), DOCA rat with normal diet 
control (D-N-C), tempol treated DOCA rat with normal diet (D-N-T), losartan 
treated DOCA rat with normal diet (D-N-L) and tempol & losartan treated DOCA rat 
with normal diet (D-N-TL) groups 80 
3.3.1 Body weight 80 
3.3.2 Water intake 81 
3.3.4 Mean arterial blood pressure, systolic blood pressure, diastolic blood 
pressure and heart rate 83 
3.3.5 Plasma creatinine, urine creatinine and creatinine clearance 85 
3.3.6 Plasma & urinary sodium and potassium 86 
 vi 
 
3.3.7 Absolute sodium excretion and fractional sodium excretion 89 
3.3.8 Urinary sodium to potassium ratio 90 
3.3.9 Pulse wave velocity and baseline renal cortical blood perfusion 91 
3.3.10 Renal Vasoconstrictor responses 92 
3.3.10 (a) Noradrenaline 92 
3.3.10 (b) Phenylephrine 93 
3.3.10 (c) Methoxamine 94 
3.3.10 (d) Angiotensin II 95 
3.4 Results of SD rat with normal diet control (SD-N-C), DOCA rat with sodium diet 
control (D-S-C), tempol treated DOCA rat with sodium diet (D-S-T), losartan treated 
DOCA rat with sodium diet (D-S-L) and tempol & losartan treated DOCA rat with 
sodium diet (D-S-TL) groups 96 
3.4.1 Body weight 96 
3.4.2 Water intake 96 
3.4.3 Urine flow rate and urine output 97 
3.4.4 Mean arterial blood pressure, systolic blood pressure, diastolic blood 
pressure and heart rate 99 
3.4.5 Plasma creatinine, urine creatinine and creatinine clearance 102 
3.4.6 Plasma & urinary sodium and potassium 104 
3.4.7 Absolute sodium excretion and fractional sodium excretion 107 
3.4.8 Urinary sodium to potassium ratio 109 
3.4.9 Pulse wave velocity and baseline renal cortical blood perfusion 110 
3.4.10 Renal Vasoconstrictor responses 110 
3.4.10 (a) Noradrenaline 110 
3.4.10 (b) Phenylephrine 112 
3.4.10 (c) Methoxamine 113 
3.4.10 (d) Angiotensin II 114 
 
CHAPTER 4: DISCUSSION 195 
4.1 Body weight, water intake and urine flow rate 198 
4.2 Mean arterial blood pressure, systolic blood pressure, diastolic blood pressure 
and heart rate  203 
4.3 Renal haemodynamic and functional parameters 208 
4.4 Pulse wave velocity 217 
4.5 Renal vasoconstrictor responses 217 
 
CHAPTER 5: CONCLUSION 224 
REFERENCES 226 
 vii 
 
APPENDICES I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 viii 
 
LIST OF TABLES 
 Page 
Table 2.1: Experimental groups 35 
 
Table 2.2:  List of chemicals and their suppliers 50 
 
Table 2.3: List of equipment and their suppliers 51 
 
Table 3.1.1:  Water intake, urine output, plasma sodium and plasma  115 
 potassium of SD-N-C, SD-N-T, SD-N-L and SD-N-TL groups.   
 
Table 3.1.2:  Urinary creatinine, urinary sodium and urinary potassium  116 
 of SD-N-C, SD-N-T, SD-N-L and SD-N-TL groups.   
 
Table 3.2.1:  Water intake, urine output, plasma sodium and plasma  117 
 potassium of SD-N-C, SD-S-C, SD-S-T, SD-S-L and SD-S-TL 
groups.  
 
Table 3.2.2:  Urinary creatinine, urinary sodium and urinary potassium of 118 
 SD-N-C, SD-S-C, SD-S-T, SD-S-L and SD-S-TL groups. 
 
Table 3.3.1:  Water intake, urine output, plasma sodium and plasma  119 
 potassium of SD-N-C, D-N-C, D-N-T, D-N-L and D-N-TL 
groups.   
 
Table 3.3.2:  Urinary creatinine, urinary sodium and urinary potassium of 120 
 SD-N-C, D-N-C, D-N-T, D-N-L and D-N-TL groups.   
 
Table 3.4.1:  Water intake, urine output, plasma sodium and plasma  121 
 potassium of SD-N-C, D-S-C, D-S-T, D-S-L and D-S-TL 
groups.   
 
Table 3.4.2:  Urinary creatinine, urinary sodium and urinary potassium of 122 
 SD-N-C, D-S-C, D-S-T, D-S-L and D-S-TL groups.  
 
 
  
 ix 
 
LIST OF FIGURES 
          Page 
Figure 2.1: The schematic experimental protocol. 36 
 
Figure 3.1:  Body weight of SD-N-C, SD-N-T, SD-N-L and SD-N-TL  123 
 groups. 
 
Figure 3.2:  Urine flow rate of SD-N-C, SD-N-T, SD-N-L and SD-N-TL 123 
 groups.  
 
Figure 3.3:  Mean arterial blood pressure of SD-N-C, SD-N-T, SD-N-L  124 
  and SD-N-TL groups.  
 
Figure 3.4:  Systolic blood pressure of SD-N-C, SD-N-T, SD-N-L and  124 
 SD-N-TL groups.   
 
Figure 3.5:  Diastolic blood pressure of SD-N-C, SD-N-T, SD-N-L and  125 
 SD-N-TL groups.   
 
Figure 3.6:  Plasma creatinine of SD-N-C, SD-N-T, SD-N-L and  125 
 SD-N-TL groups.   
 
Figure 3.7:  Creatinine clearance of SD-N-C, SD-N-T, SD-N-L and  126 
 SD-N-TL groups.  
 
Figure 3.8:  Absolute sodium excretion (UNaV) of SD-N-C, SD-N-T,  126 
 SD-N-L and SD-N-TL groups.   
 
Figure 3.9:  Fractional sodium excretion (FENa) of SD-N-C, SD-N-T,  127 
 SD-N-L and SD-N-TL groups.  
 
Figure 3.10:  Urinary sodium potassium ratio (Na
+
: K
+
) of SD-N-C,  127 
 SD-N-T, SD-N-L and SD-N-TL groups.  
 
Figure 3.11:  Pulse wave velocity of SD-N-C, SD-N-T, SD-N-L and  128 
 SD-N-TL groups. 
 
Figure 3.12:  Baseline renal cortical blood perfusion of SD-N-C,  128 
 SD-N-T, SD-N-L and SD-N-TL groups. 
 
Figure 3.13:  The overall mean percentage drop of renal cortical blood  129 
 perfusion in response to noadrenaline of SD-N-C, SD-N-T,  
 SD-N-L and SD-N-TL groups.  
 
Figure 3.14: The overall mean percentage drop of renal cortical blood  129 
 perfusion in response to phenylephrine of SD-N-C, SD-N-T, 
SD-N-L and SD-N-TL groups.  
 
 x 
 
Figure 3.15:  The overall mean percentage drop of renal cortical blood  130 
 perfusion in response to methoxamine of SD-N-C, SD-N-T, 
SD-N-L and SD-N-TL groups.  
 
Figure 3.16:  The overall mean percentage drop of renal cortical blood  130 
 perfusion in response to angiotensin II of SD-N-C, SD-N-T, 
SD-N-L and SD-N-TL groups.  
 
Figure 3.17:  The mean percentage drop of renal cortical blood perfusion  131 
 in response to graded doses of noadrenaline in SD-N-C, SD-N-
T, SD-N-L and SD-N-TL groups.  
 
Figure 3.18:  The mean percentage drop of renal cortical blood perfusion  132 
 in response to graded doses of phenylephrine in SD-N-C, SD-
N-T, SD-N-L and SD-N-TL groups.  
 
Figure 3.19:  The mean percentage drop of renal cortical blood perfusion  133 
 in response to graded doses of methoxamine in SD-N-C, SD-N-
T, SD-N-L and SD-N-TL groups.  
 
Figure 3.20:  The mean percentage drop of renal cortical blood perfusion 134 
  in response to graded doses of angiotensin II in SD-N-C, SD-
N-T, SD-N-L and SD-N-TL groups 
 
Figure 3.21:  Body weight of SD-N-C, SD-S-C, SD-S-T, SD-S-L and  135 
 SD-S-TL groups.  
 
Figure 3.22:  Urine flow rate of SD-N-C, SD-S-C, SD-S-T, SD-S-L and  136 
 SD-S-TL groups.  
 
Figure 3.23:  Mean arterial blood pressure of SD-N-C, SD-S-C, SD-S-T,  137 
 SD-S-L and SD-S-TL groups.  
 
Figure 3.24:  Systolic blood pressure of SD-N-C, SD-S-C, SD-S-T, SD-S-L  138 
 and SD-S-TL groups.  
 
Figure 3.25:  Diastolic blood pressure of SD-N-C, SD-S-C, SD-S-T, SD-S-L  139 
 and SD-S-TL groups.  
 
Figure 3.26:  Plasma creatinine of SD-N-C, SD-S-C, SD-S-T, SD-S-L and  140 
 SD-S-TL groups.  
 
Figure 3.27:  Creatinine clearance of SD-N-C, SD-S-C, SD-S-T, SD-S-L  141 
 and SD-S-TL groups.  
 
Figure 3.28:  Absolute sodium excretion (UNaV) of SD-N-C, SD-S-C,  142 
 SD-S-T, SD-S-L and SD-S-TL groups. 
 
Figure 3.29:  Fractional sodium excretion (FENa) of SD-N-C, SD-S-C,  143 
 SD-S-T, SD-S-L and SD-S-TL groups.  
 xi 
 
Figure 3.30:  Urinary sodium potassium ratio (Na
+
: K
+
) of SD-N-C, SD-S-C,  144 
 SD-S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.31:  Pulse wave velocity and of SD-N-C, SD-S-C, SD-S-T, SD-S-L  145 
 and SD-S-TL groups.  
 
Figure 3.32:  Baseline renal cortical blood perfusion of SD-N-C, SD-S-C,  145 
 SD-S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.33:  The overall mean percentage drop of renal cortical blood  146 
 perfusion in response to noadrenaline of SD-N-C, SD-S-C, SD-
S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.34:  The overall mean percentage drop of renal cortical blood  146 
 perfusion in response to phenylephrine of SD-N-C, SD-S-C, 
SD-S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.35:  The overall mean percentage drop of renal cortical blood  147 
 perfusion in response to methoxamine of SD-N-C, SD-S-C, 
SD-S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.36:  The overall mean percentage drop of renal cortical blood  147 
 perfusion in response to angiotensin II of SD-N-C, SD-S-C, 
SD-S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.37:  The mean percentage drop of renal cortical blood perfusion in  148 
 response to graded doses of noadrenaline in SD-N-C, SD-S-C, 
SD-S-T, SD-S-L and SD-S-TL groups.  
 
Figure 3.38:  The mean percentage drop of renal cortical blood perfusion in  150 
 response to phenylephrine, of SD-N-C, SD-S-C, SD-S-T, SD-
S-L and SD-S-TL groups.  
 
Figure 3.39:  The mean percentage drop of renal cortical blood perfusion in  152 
 response to methoxamine of SD-N-C, SD-S-C, SD-S-T, SD-S-
L and SD-S-TL groups.  
 
Figure 3.40:  The mean percentage drop of renal cortical blood perfusion in  154 
 response to angiotensin II of SD-N-C, SD-S-C, SD-S-T, SD-S-
L and SD-S-TL groups.  
 
Figure 3.41: Body weight of SD-N-C, D-N-C, D-N-T, D-N-L and D-N-TL  155 
 groups.  
 
Figure 3.42: Urine flow rate of SD-N-C, D-N-C, D-N-T, D-N-L and  156 
 D-N-TL groups.  
 
Figure 3.43:  Mean arterial blood pressure of SD-N-C, D-N-C, D-N-T,  157 
 D-N-L and D-N-TL groups.  
 
 xii 
 
Figure 3.44:  Systolic blood pressure of SD-N-C, D-N-C, D-N-T, D-N-L  158 
 and D-N-TL groups.  
 
Figure 3.45:  Diastolic blood pressure of SD-N-C, D-N-C, D-N-T, D-N-L  159 
 and D-N-TL groups.  
 
Figure 3.46: Plasma creatinine of SD-N-C, D-N-C, D-N-T, D-N-L and  160 
 D-N-TL groups.  
 
Figure 3.47:  Creatinine clearance of SD-N-C, D-N-C, D-N-T, D-N-L and 161  
 D-N-TL groups.  
 
Figure 3.48:  Absolute sodium excretion (UNaV) of SD-N-C, D-N-C, D-N-T,  162 
 D-N-L and D-N-TL groups.  
 
Figure 3.49:  Fractional sodium excretion (FENa) of SD-N-C, D-N-C,  163 
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.50:  Urinary sodium potassium ratio (Na
+
: K
+
) of SD-N-C, D-N-C,  164 
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.51:  Pulse wave velocity of SD-N-C, D-N-C, D-N-T, D-N-L and  165 
 D-N-TL groups.  
 
Figure 3.52:  Baseline renal cortical blood perfusion of SD-N-C, D-N-C,  165 
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.53:  The overall mean percentage drop of renal cortical blood  166 
 perfusion in response to noradrenaline of SD-N-C, D-N-C,  
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.54:  The overall mean percentage drop of renal cortical blood  166 
 perfusion in response to phenylephrine of SD-N-C, D-N-C,  
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.55:  The overall mean percentage drop of renal cortical blood  167 
 perfusion in response to methoxamine of SD-N-C, D-N-C,  
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.56:  The overall mean percentage drop of renal cortical blood  167 
 perfusion in response to angiotensin II of SD-N-C, D-N-C,  
 D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.57:  The mean percentage drop of renal cortical blood perfusion in  168 
 response to graded doses of noradrenaline in SD-N-C, D-N-C, 
D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.58:   The mean percentage drop of renal cortical blood perfusion in  170 
 response to graded doses of phenylephrine in SD-N-C, D-N-C, 
D-N-T, D-N-L and D-N-TL groups.  
 xiii 
 
Figure 3.59:  The mean percentage drop of renal cortical blood perfusion in  172 
 response to graded doses of methoxamine in SD-N-C, D-N-C, 
D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.60:  The mean percentage drop of renal cortical blood perfusion in  174 
 response to graded doses of angiotensin II in SD-N-C, D-N-C, 
D-N-T, D-N-L and D-N-TL groups.  
 
Figure 3.61:  Body weight of SD-N-C, D-S-C, D-S-T, D-S-L and D-S-TL  175 
 groups.  
 
Figure 3.62:  Urine flow rate of SD-N-C, D-S-C, D-S-T, D-S-L and D-S-TL  176 
 groups.  
 
Figure 3.63:  Mean arterial blood pressure of SD-N-C, D-S-C, D-S-T, D-S-L  177 
 and D-S-TL groups.  
 
Figure 3.64:  Systolic blood pressure of SD-N-C, D-S-C, D-S-T, D-S-L  178 
 and D-S-TL groups.  
 
Figure 3.65:  Diastolic blood pressure of SD-N-C, D-S-C, D-S-T, D-S-L and  179 
 D-S-TL groups.  
 
Figure 3.66:  Plasma creatinine of SD-N-C, D-S-C, D-S-T, D-S-L and  180 
 D-S-TL groups.  
 
Figure 3.67:  Creatinine clearance of SD-N-C, D-S-C, D-S-T, D-S-L and  181 
 D-S-TL groups.  
 
Figure 3.68:  Absolute sodium excretion (UNaV) of SD-N-C, D-S-C, D-S-T,  182 
 D-S-L and D-S-TL groups.  
 
Figure 3.69:  Fractional sodium excretion (FENa) of SD-N-C, D-S-C, D-S-T,  183 
 D-S-L and D-S-TL groups.  
 
Figure 3.70:  Urinary sodium potassium ratio (Na
+
: K
+
) of SD-N-C, D-S-C,  184 
 D-S-T, D-S-L and D-S-TL groups.   
 
Figure 3.71:  Pulse wave velocity of SD-N-C, D-S-C, D-S-T, D-S-L and  185 
 D-S-TL groups.  
 
Figure 3.72:  Baseline renal cortical blood perfusion of SD-N-C, D-S-C,  185 
 D-S-T, D-S-L and D-S-TL groups.  
 
Figure 3.73:  The overall mean percentage drop of renal cortical blood  186 
 perfusion in response to noradrenaline of SD-N-C, D-S-C, D-S-
T, D-S-L and D-S-TL groups.  
 
 
 
 xiv 
 
Figure 3.74:  The overall mean percentage drop of renal cortical blood  186 
 perfusion in response to phenylephrine of SD-N-C, D-S-C, D-
S-T, D-S-L and D-S-TL groups. 
 
Figure 3.75:  The overall mean percentage drop of renal cortical blood  187 
 perfusion in response to methoxamine of SD-N-C, D-S-C, D-S-
T, D-S-L and D-S-TL groups.  
 
Figure 3.76:  The overall mean percentage drop of renal cortical blood  187 
 perfusion in response to angiotensin II of SD-N-C, D-S-C, D-S-
T, D-S-L and D-S-TL groups.  
 
Figure 3.77: The mean percentage drop of renal cortical blood perfusion in  188 
 response to graded doses of noradrenaline in SD-N-C, D-S-C, 
D-S-T, D-S-L and D-S-TL groups.  
 
Figure 3.78:  The mean percentage drop of renal cortical blood perfusion in  190 
 response to graded doses of phenylephrine in SD-N-C, D-S-C, 
D-S-T, D-S-L and D-S-TL groups.  
 
Figure 3.79: The mean percentage drop of renal cortical blood perfusion in  192 
 response to graded doses of methoxamine in SD-N-C, D-S-C, 
D-S-T, D-S-L and D-S-TL groups.  
 
Figure 3.80:  The mean percentage drop of renal cortical blood perfusion in  194 
 response to graded doses of angiotensin II in SD-N-C, D-S-C, 
D-S-T, D-S-L and D-S-TL groups.  
 
 
 
  
 xv 
 
LIST OF ABBREVATIONS  
 
Abs.  Absorbance 
Ang II  Angiotensin II 
AT1  Angiotensin II type 1 receptor 
BP  Blood pressure 
CONC  Concentration 
DOCA  Deoxycorticosterone acetate 
GFR  Glomerular filtration rate  
HR  Heart rate 
I.P.  Intraperitoneally 
K
+ 
 Ion potassium  
KI  Kidney index 
MAP  Mean arterial pressure 
ME  Methoxamine 
NA  Noradrenaline 
Na
+ 
 Ion natrium 
NaOH  Sodium hydroxide 
PE  Phenylephrine 
PWV  Pulse wave velocity 
RCBF  Renal cortical blood flow 
ROS  Reactive oxygen species  
SBP  Systolic blood pressure 
S.C.  Subcutaneously 
SD  Sprague Dawley 
 xvi 
 
SHR  Spontaneously hypertensive rat 
Tempol 4-hydroxy-2,2,6,6-tetramethyl piperidine-N-oxyl 
USM  Universiti Sains Malaysia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 xvii 
 
α1-ADRENOSEPTOR DAN AT1 RESEPTOR MEMODULASI 
HEMODINAMIK GINJAL DALAM TIKUS HIPERTENSIF MODEL 
GARAM LEBIHAN DAN DOCA YANG DIRAWAT DENGAN TEMPOL 
DAN LOSARTAN 
 
ABSTRAK 
 
Hipertensi merupakan penyebab utama morbiditi dan kematian yang berkait 
rapat dengan kerosakan ginjal. Pengambilan garam lebihan menyumbang kepada 
pathogenesis hipertensi. Reseptor adrenergik-α1 menyumbang kepada modulasi nada 
vaskular ginjal untuk mengawal tekanan darah. Kajian ini telah dijalankan untuk 
mengkaji kesan tempol dan losartan ke atas fungsi dan hemodinamik ginjal dalam 
model tikus Sprague Dawley (SD) dengan diet biasa, model tikus SD dengan garam 
lebihan, model tikus DOCA dengan diet biasa dan model tikus DOCA dengan garam 
lebihan. Semua tikus model dibahagikan kepada kumpulan kawalan, tempol 
(3mmol/l), losartan (10mg/kg, 7 hari terakhir) dan tempol bercampur losartan. Semua 
model tikus telah dikaji selama 42 hari. Kajian hemodinamik ginjal dijalankan pada 
hari ke-43. Data metabolic, tekanan darah, kelajuan gelombang denyutan dan 
vaskular ginjal responsif terhadap noradrenalin (NA), phenylephrine (PE), 
methoxamine (ME) dan angiotensin II (Ang II) telah dikajikan. Data analisis 
membandingkan min ± SEM menggunakan ANOVA satu/dua hala dengan paras 
signifikan 5%. Tempol dan losartan tidak mempengaruhi fungsi ginjal dan 
vasculature ginjal responsif dalam tikus-tikus SD dengan diet biasa. Tikus-tikus SD 
dengan garam lebihan mengalami kenaikan tekanan darah dan kerosakan ginjal yang 
terbukti berdasarkan kreatinin plasma yang meningkat, klearans kreatinin yang 
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menurun dan pengurangan nisbah natrium: kalium. Tikus-tikus DOCA dengan garam 
lebihan mengalami kenaikan tekanan darah dan ginjal tidak berfungsi yang tersokong 
berdasarkan kreatinin plasma yang meningkat, klearans kreatinin yang menurun dan 
penurunan dalam perkumuhan pecahan natrium. Tempol menurunkan tekanan darah 
dalam  model tikus SD dengan garam lebihan, model tikus DOCA dengan diet biasa 
dan model tikus DOCA dengan garam lebihan. Losartan mengurangkan tekanan 
darah tinggi dalam tikus-tikus SD dengan garam lebihan. Pengurangan tindakbalas 
perfusi darah kortikal ginjal terhadap agonis adrenergik membuktikan garam lebihan 
telah menurun responsif reseptor adrenergik-α1 ginjal dalam tikus-tikus SD dengan 
garam lebihan dan tikus-tikus DOCA dengan garam lebihan. Garam lebihan menurun 
sensitiviti AT1-reseptor dalam tikus-tikus SD dengan garam lebihan. Tempol 
memperbaki peratusan penurunan perfusi darah kortikal ginjal terhadap agonis 
adrenergik dalam tikus-tikus SD dengan garam lebihan. Losartan menaikan reseptor 
adrenergik-α1 responsif dan menurunkan kepekaan AT1-receptor dalam tikus-tikus 
DOCA dengan garam lebihan. Tempol bercampur losartan memperbaiki peratusan 
penurunan perfusi darah kortikal ginjal terhadap agonis adrenergic dalam tikus-tikus 
SD dengan garam lebihan dan tikus-tikus DOCA dengan diet biasa. Dapatan kajian 
ini mencadangkan bahawa tempol merendahkan tekanan darah dan memperbaiki α1-
adrenoreseptor sensitif yang mampu memberi perlindungan daripada spesies oksigen 
reaktif dalam model tikus hipertensi.  
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α1-ADRENOCEPTORS AND AT1 RECEPTORS IN MODULATION OF 
RENAL HEMODYNAMICS IN HIGH SALT AND DOCA MODELS OF 
HYPERTENSIVE RATS TREATED WITH TEMPOL AND LOSARTAN 
 
ABSTRACT 
 
Hypertension is a major cause of morbidity and mortality from renal 
impairment. An increase of sodium intake contributes to the pathogenesis of 
hypertension. α1-adrenoceptors modulate renal vascular tone in the regulation of 
blood pressure. This study was undertaken to investigate the effects of tempol and 
losartan on renal function and haemodynamics in Sprague Dawley (SD) rats fed with 
normal diet, SD rats fed with high sodium diet, DOCA-salt treated rats fed with 
normal diet and DOCA-salt treated rats fed with high sodium diet. All models were 
divided into groups of control, tempol (3mmol/l), losartan (10mg/kg, last 7 days) and 
combination of tempol and losartan. The animals were studied for 42 days. The acute 
renal hemodynamic study was performed on day 43. Metabolic data, blood pressure 
(BP), pulse wave velocity (PWV) and renal vascular responsiveness to noradrenaline 
(NA), phenylephrine (PE), methoxamine (ME) and angiotensin II (Ang II) were 
investigated. Data, mean ± SEM were analyzed using one/two-way ANOVA with 
significance level of 5%. Tempol and losartan did not influence renal function and 
renal vasculature responsiveness in SD rats fed with normal diet. SD rats given with 
high sodium diet showed higher BP and renal impairment as evidenced by increased 
plasma creatinine, creatinine clearance and decreased urinary sodium to potassium 
ratio. DOCA-salt rats fed with high sodium diet had higher BP and in renal function 
compromised as supported by increased plasma creatinine, decreased creatinine 
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clearance and increased fractional sodium excretion. Tempol decreased BP of SD 
rats fed with high sodium diet, DOCA-salt treated rats fed with normal diet and 
DOCA-salt treated rats fed with high sodium diet. Similarly, losartan reduced BP in 
SD rats fed with high sodium diet. High sodium diet decreased the responsiveness of 
renal α1-adrenoceptors in SD rats fed with high sodium diet and DOCA-salt rats fed 
with high sodium diet as supported by decreased renal cortical blood perfusion 
(RCBP) in response to adrenergic agonists. High sodium diet also decreased 
sensitivity of AT1-receptors in SD rats fed with high sodium diet. Tempol increased % 
drop of RCBP in response to adrenergic agonists in SD rats fed with high sodium 
diet. Similarly, losartan increased the responsiveness of α1-adrenergic receptors and 
decreased the sensitivity of AT1-receptors in DOCA-salt rats fed with high sodium 
diet. Tempol and losartan given in combination increased % drop of RCBP in 
response to adrenergic agonists in SD rats fed with high sodium diet and DOCA-salt 
rats fed with normal diet. Collectively, the results suggest that tempol lowers MAP 
and improves sensitivity of α1-adrenoceptors thus providing protection against ROS 
in these hypertensive rat models.  
 
 
 
1 
CHAPTER 1 
INTRODUCTION 
 
Epidemiological and scientific studies have reported that sodium 
consumption is very high in our daily diets (Brown et al., 2009; Li et al., 2012). 
Previous experimental and clinical studies mentioned the vital role of sodium in the 
regulation of blood pressure and the implications of abnormal sodium balance in the 
development of hypertension (Esteva-Font et al., 2010; Koga et al., 2008; Kuller, 
1997; Logan, 2006). Studies have also indicated that a long-term high sodium dietary 
intake contributes to elevated blood pressure (Johns, 2002) especially when the 
kidneys have a decreased function of sodium excretion (Ogihara et al., 2003). It can 
be explained that a decreased function of kidney to excrete sodium would cause 
sodium and water retention. Then, it leads to an increased extracellular fluid and 
increased plasma volume resulting into an elevated blood pressure. Restriction in 
sodium intake has been shown to decrease the blood pressure (Karppanen and 
Mervaala, 2006). Independent of excess sodium intake effect on blood pressure, it 
also increases left ventricular hypertrophy as well as fibrosis in kidneys and arteries 
(Appel et al., 2011). 
 
Experimental work on the pressure natriuresis and diuresis relationship 
developed by Guyton confirmed kidneys played a role in blood pressure regulation 
(Guyton, 1991). However, there are also many systems and mechanisms involved in 
arterial blood pressure regulation such as the baroreceptor mechanism, the 
chemoreceptor system, the central nervous system ischemic response, the renin-
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angiotensin-vasoconstrictor mechanism, the stress relaxation mechanism, the 
capillary fluid shift mechanism, the renal-body fluid mechanism and the aldosterone 
mechanism (Guyton et al., 1972). These mechanisms and systems regulate blood 
pressure by modulating cardiac output, fluid volumes and peripheral vascular 
resistance.  
 
The decreased function of the kidney to excrete sodium is different from 
individual to individual. Those require a higher than the normal levels of blood 
pressure to excrete sodium are called to be salt-sensitive. However, those can excrete 
excess salt at normal level of blood pressure are known as salt-resistant. Several 
mechanisms responsible for decreased salt-sensitivity have been reported such as 
defect in renal function (Campese, 1994), abnormally increasing reactive oxygen 
species generation leading to impairment in the endothelial derived relaxing factor 
nitric oxide activity (Lenda et al., 2000) and abnormally high activation of intra-renal 
renin-angiotensin system (Redgrave et al., 1985).  
 
 
 
 
 
 
 
 
 
 
 3 
 
1.1 Urinary system 
1.1.1 Kidney 
Both kidneys are reddish and bean shaped organs. They are located in the 
retroperitoneal cavity of abdomen. The kidneys are located on either side at the level 
of the twelve thoracic to the third lumbar vertebrae. The right kidney is slightly lower 
in position than the left because the liver takes up some of the space above the right 
kidney (Grabowski and Tortora, 2003). Three layers of tissues surround kidneys; 
renal capsule (deep layer), adipose capsule (middle layer) and renal fascia 
(superficial layer). A mass of adipose tissue encases each kidney and holds it in its 
position. The renal capsule and the renal fasciae anchors the kidneys to surrounding 
structures and helps maintain their positions (Thibodeau and Patton, 2007).  
 
The medial border of the kidney has a concave notch called hilus that allows 
structures to enter or leave kidney along with blood vessels, lymphatic vessels, and 
nerves. The frontal section through the kidney reveals two regions that are renal 
cortex or the superficial region and renal medulla or the inner region. The renal 
pyramids make up the medullary tissue. The base of each pyramid faces the renal 
cortex and each renal papilla faces toward the renal hilus (Grabowski and Tortora, 
2003). The cortical tissue extends into the medulla between the pyramids to form 
renal columns. The renal papilla drain into cupslike structure called calyces where 
urine is received from the renal papilla, drained into renal pelvis and then transported 
out of the body through the ureters to the urinary bladder and urethras (Thibodeau 
and Patton, 2007). 
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The ureters are two tubes which are 25 to 30cm in length and transport urine 
from the renal pelvis to the urinary bladder (Grabowski and Tortora, 2003). The 
ureters curve medially from the renal pelvis until reaches through the bladder wall 
and opens at the lateral angle of the trigone in the urinary bladder (Thibodeau and 
Patton, 2007). Each ureter is formed of three layers of tissues which are the mucosa 
or the deepest layer, the muscularis or the intermediate layer and the adventitia or the 
superficial layer. The muscular layer is composed of smooth muscle fibers which 
play a major function in peristalsis to propel urine. The peristalsis waves vary in 
frequency rate and are dependent on how fast the urine is being formed (Grabowski 
and Tortora, 2003).  
 
The urinary bladder is a muscular and distensible bag organ which is situated 
directly behind the pubis symphysis and in front of the pelvic cavity (Grabowski and 
Tortora, 2003). It lies below the parietal peritoneum which covers only its superior 
surface. The remainder of the bladder surface is covered by a fibrous adventitia 
whereas the wall of the bladder is made up of smooth muscles (Thibodeau and Patton, 
2007). The urinary bladder is lined with mucous transitional epithelium that forms 
folds called rugae to permit expansion (Grabowski and Tortora, 2003). There are 
three openings in the bladder, two from the ureters and one into the urethra, which 
helps in urine drainage from the body (Thibodeau and Patton, 2007). The function of 
urinary bladder is to store and excrete urine (Andersson and Arner, 2004).  
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The urethra is a small tube lined with mucous membrane that emerges from 
the floor of the urinary bladder to the exterior of the body. In both male and female, 
the urethra is the last part of urinary system for propelling urine out from the body. In 
males, the urethra extends about 20cm, which passes through the center of the 
prostate gland just after leaving the urinary bladder (Thibodeau and Patton, 2007). 
The urethra is joined by two ejaculatory ducts within the prostate. After leaving the 
prostate, the urethra extends down and enters the base of the penis. The urethra 
travels through the center of the penis and ends as a urinary meatus at the tip of the 
penis. In female, the urethra lies directly posterior to the pubis symphysis and 
anterior to the vagina as it passes through the muscular floor of the pelvis. The 
urethra extends down and forward from the bladder for about 3cm and ends at the 
external urinary meatus (Thibodeau and Patton, 2007).   
 
The main functions of the kidneys are to process blood plasma and excrete 
urine in order to maintain the homeostatic balance of the body. The kidneys are the 
most important organs in the body for maintaining fluid electrolyte and acid-base 
balance as well as excreting wastes. They also regulate blood pH, blood volume and 
blood glucose levels as well as synthesize the active form of vitamin D and certain 
prostaglandins. The kidneys influence the secretion rate of antidiuretic hormone 
(ADH) and aldosterone (Grabowski and Tortora, 2003). Kidney plays crucial role in 
controlling and regulating blood pressure (BP) by handling sodium and water 
balance (Gu et al., 2008). Kidneys promote natriuresis and diuresis according to 
different sodium intake in order to maintain normal BP and the development of 
essential hypertension (De Richelieu et al., 2005). 
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1.1.2 Nephron  
Nephron is the basic structural and functional unit of the kidney. The function 
of nephron includes blood plasma processing and urine formation by means of three 
processes. These three processes are filtration, tubular reabsorption and tubular 
secretion. A hydrostatic pressure gradient drives the filtration of the plasma into the 
nephron. The filtrate contains materials that the body must save, the walls of the 
tubules reabsorb these materials back into the blood. As the filtrate begins to leave 
the nephron, the kidney may secrete a few items into the urine for excretion. There 
are two general classes of nephrons which are cortical nephrons and juxtamedullary 
nephrons. Almost all cortical nephrons are located in the renal cortex whereas 
juxtamedullary nephrons lie near the junction of the cortical and medullary layers 
(Thibodeau and Patton, 2007). The structure of nephron includes renal corpuscle, 
Bowman’s capsule, proximal convoluted tubule, loop of Henle, distal convoluted 
tubule and collecting duct.  
 
Filtration is the first step of urine production in which water and small solutes 
of blood filter out and move across glomerular capillaries into Bowman’s capsules 
(Grabowski and Tortora, 2003). Larger cells and plasma proteins do not filter into the 
Bowman’s capsules. The filtration takes place through the glomerular capsular 
membrane. Glomerular filtration depends on systemic blood pressure, a decreased 
blood pressure tends to decrease both glomerular pressure and filtration rate 
(Grabowski and Tortora, 2003). Increase in blood pressure results in constriction of 
afferent arterioles in order to maintain the blood flow to the kidney thereby 
maintaining glomerlar pressure and glomerular filtration (Thibodeau and Patton, 
2007).  
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Reabsorption is the second step in urine formation, which involves passive 
and active transport mechanisms from all parts of the renal tubules. The proximal 
tubule reabsorbs all nutrients and major portion of water and electrolytes back into 
blood stream. The rest of the renal tubule reabsorbs comparatively little of the filtrate.  
 
Tubular secretion means the movement of substances out of the blood and 
into tubular fluids. The descending limb of the loop of Henle removes urea through 
diffusion. The distal and collecting tubules secrete potassium, hydrogen, and 
ammonium ions (Grabowski and Tortora, 2003). They actively transport potassium 
ions or hydrogen ions out of the blood into tubule fluid in exchange for sodium ions 
that diffuse back into the blood. Potassium ion secretion increases when the blood 
aldosterone concentration increases. Aldosterone is a hormone of the adrenal cortex, 
which targets distal and collecting tubule cells to increase the activity of the sodium-
potassium pumps that move sodium ion out of the tubule and potassium ion into the 
tubule. Hydrogen ion secretion increases when the blood hydrogen ion concentration 
increases. Ammonium ions are secreted into the tubular fluid by diffusing out of the 
tubule cells where they are synthesized (Thibodeau and Patton, 2007).  
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1.1.2 (a) Renal corpuscle and glomerulus 
The renal corpuscle is composed of the Bowman's capsule and glomerulus. 
The renal corpuscle is the nephron's beginning filtering component of the kidney. 
The Bowman’s capsule is the cup-shaped mouth of a nephron which surrounds the 
glomerulus. It is formed by two layers of epithelial cells with a space called 
Bowman’s space. Fluids, waste products and electrolytes are filtered through the 
capillaries of the glomerulus into the Bowman’s space and constitute the glomerular 
filtrate which will be processed in the nephron to form urine. At the beginning of the 
nephron, the glomerulus is a network of fine capillaries that performs the first step of 
filtering blood. Glomeruli have thin and membranous walls that are composed of a 
single layer of endothelial cells. Many pores are present in the glomerular 
endothelium, which are larger than other pores of regular capillaries. This increased 
porosity is necessary for filtration to occur at the rate required for normal kidney 
function. Thus, glomerular filtration rate (GFR) is accepted as the measure of the 
overall kidney function (Stevens et al., 2006). 
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1.1.2 (b) Proximal tubule 
The proximal tubule is the second part of the nephron but the first part of the 
renal tubule. Its wall consists of one layer of epithelial cells. The luminal surface of 
the epithelial cells is covered with numerous amounts of microvilli that form the 
brush border. The proximal tubule regulates the pH of the filtrate and secretes 
organic acids, such as creatinine and other bases into the filtrate. Sodium ions, water, 
potassium ions, urea, phosphate ions, citrate ions which enter the proximal 
convoluted tubule are partly reabsorbed into the peritubular capillaries (Grabowski 
and Tortora, 2003). Most of filtrate that enters the renal tubule from Bowman’s 
capsule is reabsorbed before it reaches the end of the proximal tubule and only a 
small volume of filtrate is left to continue to the next portion of the loop of Henle. 
Sodium ions are actively transported out of the lumen of the tubule and into 
peritubular blood. As sodium ions accumulate in the interstitial fluid and become 
temporarily positive with respect to the tubule fluid. This electrical gradient drives 
the diffusion of negative ions from the filtrate into the interstitial fluid and then into 
the peritubular blood. The attraction between negative and positive ions is used to 
drive the passive transport of chloride, phosphate and other negative ions out of the 
tubule. Ion transports out of the proximal tubules causes water osmosis out of the 
tubule and into the peritubular blood and makes the two fluids isotonic. Proximal 
tubules reabsorb nutrients from the tubule fluid, glucose and amino acids into 
peritubular blood by a type of active transport mechanism called sodium cotransport. 
Glucose and amino acids passively move out of the tubule fluid by means of the 
sodium cotransport mechanism (Thibodeau and Patton, 2007).  
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1.1.2 (c) Loop of Henle 
The loop of Henle is the segment of renal tubule just beyond the proximal 
tubule. It consists of a descending limb and an ascending limb. The descending limb 
has low permeability to ions and urea but highly permeable to water. The ascending 
limb is impermeable to water but permeable to ions. The cortical ascending limb 
drains urine into the distal tubule. The length of the loop of Henle is important in the 
production of concentrated or diluted urine (Thibodeau and Patton, 2007).  The 
descending loop of Henle receives isotonic fluid from the proximal tubule, then 
reabsorbs water from tubule fluid and picks up urea from the interstitial fluid. The 
volume of fluid in the loop of Henle is lesser than the fluid in proximal tubule. The 
ascending limb of the loop of Henle gets a lower volume of fluid as compared to the 
descending limb. In contrast, the ascending portion of the loop of Henle becomes 
impermeable to water but extremely permeable to ions. Sodium and chloride ions are 
actively reabsorbed from the tubule fluid in the ascending limb. By reabsorbing 
sodium ions from the ascending limb of the loop of Henle, this can cause the tubule 
fluid to be diluted. Reabsorption of sodium ions in the ascending limb also creates 
and maintains a high solute concentration of the medullary interstitial fluid 
(Thibodeau and Patton, 2007). 
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1.1.2 (d) Distal tubule and collecting duct 
The distal tubule is located between the loop of Henle and the collecting duct 
system. The juxtaglomerular apparatus is found at the point where the afferent 
arteriole brushes past the distal tubule. This structure is important in maintaining 
homeostasis of blood flow because it reflexively secretes renin when blood pressure 
in the afferent arteriole drops. Renin triggers a mechanism that produces angiotensin, 
which causes vasoconstriction and the resulting increase in blood pressure. Large 
smooth muscle cells in the wall of the afferent arteriole called juxtaglomerular cells 
contain renin granules. These cells are sensitive to increased pressure in the arteriole 
and function as mechanoreceptors (Thibodeau and Patton, 2007). Modified distal 
tubule cells in the juxtaglomerular apparatus are crowded together to form a structure 
called macula densa. Cells in the macula densa are chemoreceptors that can sense the 
concentration of solute materials in the fluid passing through the tubule. Acting 
together, both cell types in the juxtaglomerular apparatus contribute to homeostasis 
of renal function by influencing the ability of the kidney to produce concentrated 
urine (Grabowski and Tortora, 2003). The function of distal tubule is similar to the 
proximal tubule, which also absorbs sodium ions by active transport but in smaller 
amounts. The distal tubule’s walls are relatively impermeable to water so that sodium 
ions can be reabsorbed but not water. As a result, the solute concentration of the 
tubule fluid continues to decrease. Apart from that, the wall structure of the 
collecting duct also prevents water from leaving the filtrate by osmosis. The 
collecting duct conducts the tubule fluid through the hypertonic medullary region 
(Thibodeau and Patton, 2007). The collecting duct of the kidney consists of a series 
of tubules and ducts which connect the nephrons to the ureter. The components of the 
collecting duct include the connecting tubules, cortical collecting ducts and 
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medullary collecting ducts. The collecting duct system is involved in ion and fluid 
balance by reabsorption and secretion processes which are regulated by the 
aldosterone and antidiuretic hormones. 
 
 A regulatory mechanism is centered outside the kidney in order to prevent 
excessive loss of water in the body. ADH is secreted by the posterior pituitary. It 
causes cells of the distal and collecting tubules to become more permeable to water. 
Then, water flows out of the tubule by osmosis and goes into the interstitial fluid in 
order to achieve equilibrium. The more ADH is present, the more water is allowed 
out of the tubule and the tubular fluid’s solute concentration matches that of the 
surrounding tissues (Thibodeau and Patton, 2007). ADH increases the solute 
concentration of the urine and decreases water excretion. ADH has a central role in 
the regulation of urine volume. Control of the solute concentration of urine translates 
into control of urine volume. If water is not  reabsorbed by the distal and collecting 
tubules, urine volume is relatively high and water loss from the body is high. ADH 
regulates the body's retention of water by acting to increase water absorption in the 
collecting ducts of the kidney nephron in order to reduce water loss by the body 
(Caldwell and Young, 2006). Aldosterone is a hormone that tends to decrease urine 
volume and conserves water (Hu et al., 2012). Aldosterone is produced from adrenal 
cortex in the adrenal gland. It increases distal and collecting tubule absorption of 
sodium, which in turn causes an osmotic imbalance that drives the reabsorption of 
water from the tubule. The water reabsorption in the distal and collecting tubule 
portions requires ADH to function. Therefore, the aldosterone mechanism works 
together with the ADH mechanism in order to maintain the homeostatsis of body. 
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 Urine analysis is often used as an indirect measure of the resulting kidney 
injury or the health status of a person. Urine contains water (Folin, 1905) along with 
nitrogenous wastes, electrolytes, toxins, pigments, hormones (Demir et al., 1994) and 
abnormal constituents. Nitrogenous wastes from protein catabolism are urea, uric 
acid, ammonia and creatinine (Bingham and Cummings, 1985). Electrolytes mainly 
present are ions such as sodium, potassium, ammonium, chloride, bicarbonate, 
phosphate, and sulfate (Shevock et al., 1993). The amounts and types of minerals 
vary with diet. During diseased state, toxins of the body are also excreted into urine 
(Le et al., 1994). Pigments like urobilin or urochromes derived from products of the 
breakdown of old red blood cells in the liver and elsewhere (De Araujo Pantoja et al., 
2012). Various types of food and drug (Drayer, 1976) may contain or be converted 
into pigments that are cleared from plasma by the kidneys into urine. Abnormal 
constituents such as blood, glucose, albumin and cast or calculi can also be found in 
urine (Atmani et al., 1996; Fogo and Barakat, 1990).  
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1.2 Blood vessels 
The kidneys are highly vascular organs which process the blood in important 
ways before returning it to the general circulation (Kang et al., 2001). There are three 
major types of blood vessels, which are arteries, veins and capillaries. Arteries carry 
oxygenated blood from the heart to the capillaries from where veins in general return 
the deoxygenated blood back to the heart (Vito and Dixon, 2003). The actual 
exchange of water and materials between blood and the tissues occurres in capillaries 
(Pappenheimer, 1953). The walls of arteries and veins consist of three separate layers 
which are tunica intima (innermost), tunica media (middle) and tunica adventitia 
(outer). The tunica intima consists of an endothelial cell monolayer which forms a 
smooth, flat and low friction surface. This layer is closest to luminal surface that 
aligns in the direction of blood flow. It also prevents blood cells including platelets, 
leukocytes and other elements from adhering to the luminal surface. Tunica media is 
also a layered structure which is made up of smooth muscle cells, elastic connective 
tissue, collagen and proteoglycans. Smooth muscle cells are responsible for 
vasoconstriction and vasodilation (Tanaka and Yamada, 1990). Endothelium of 
blood vessels are in charge of regulating vascular tone via the generation of 
vasodilator and vasoconstrictor substances (Guzik et al., 2002; Lenda et al., 2000). 
Medial elastin assists in keeping blood flow by expanding with pressure. Medial 
collagen prevents excessive dilation (Clark and Glagov, 1985). The tunica adventitia 
consists of collagen, fibroblasts and some elastin fibers. In some arterial adventitia, 
there is presence of vasa vasorum which is a vascular network.  
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1.3 Heart 
The heart is a muscular organ which can be found in all animals(Beck, 1935). 
The main function of the heart is to generate the force for blood circulation 
throughout the circulatory system by rhythmic contraction and relaxation. In humans, 
the heart is located at the centre of thoracic cavity above the diaphragm. In addition, 
the heart is about 310 grams in males and 225 grams in females. The heart rate of a 
healthy person is 72 beats per minute (Thibodeau and Patton, 2007). It is covered by 
a membranous sac called pericardium that possesses a special fluid that lubricates the 
heart when it beats. 
 
 The human heart is composed of four chambers. The upper two chambers are 
called atria which receive blood back from the vasculature system. The two lower 
chambers called ventricles which receive blood from both atria and generate the 
force to pump blood away from the heart via the blood vessels. The atria and 
ventricles are separated by a septum to prevent blood from mixing between left heart 
and right heart. The interatrial septum separates the left and right atrium, whereas the 
interventricular septum separates the left and right ventricle. The broader upper pole 
of the heart is the base and the lower pole is called the apex (Dickstein et al., 2008). 
The heart wall is made up of three layers, an epicardium (outermost), myocardium 
(middle) and endocardium (inner). The mechanical force of heart moves the wall 
inward and squeezes the blood into the chamber when the cardiac muscles in the 
atrium and ventricle walls contract. As the squeezing gradually increases, the 
pressure pushes the blood out of both atria and ventricles. When the cardiac muscle 
relaxes, the atrium and ventricle expand and fill with blood (Anderson, 2000). 
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Four sets of valves in heart are important to permit the flow of blood in only 
one direction. Atrioventricular valves are two in number which are mitral valve and 
tricuspid valve. The pulmonary semilunar valve and aortic semilunar valve are 
located  where the pulmonary artery and the aorta arise from the right and left 
ventricles, respectively (Thibodeau and Patton, 2007). Cardiac muscle cells play an 
important role in cardiac contraction. The heartbeat is modulated by pacemaker in 
the sinoatrial node. One systole followed by one diastole to form one complete 
heartbeat, which is called as one cardiac cycle.  
 
The left ventricle pumps oxygenated blood into the aorta whose branches 
deliver blood to capillary beds of all tissues and organs in the systemic circuit. The 
deoxygenated blood from the systemic tissues transports back to the heart through 
the superior vena cava into the right atrium. Then, the blood flows from the right 
atrium into the right ventricle through the tricuspid valve. From the right ventricle, 
the blood pumps into the pulmonary artery which carries the deoxygenated blood to 
the lungs for gaseous exchange.  
 
In the lungs, blood becomes oxygenated and travels to the left atrium via 
pulmonary veins. From the left atrium, blood enters through the bicuspid valve into 
the left ventricle. When the pressure in the left ventricle is very low during its 
relaxation, the phase of cardiac cycle is called diastole (Opie, 2004).   
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1.4 Adrenergic receptors  
1.4.1 Classification of adrenergic receptors 
Adrenoceptors or adrenergic receptors are a class of G protein-coupled 
receptors (GPCRs) which are found in cell membrane sites (Rosenbaum et al., 2009). 
Catecholamines, noradrenaline and adrenaline bind to adrenoceptors which act as 
important neurotransmitters and hormones in the central nervous system and 
peripheral nervous system (Guimaraes and Moura, 2001). The adrenoceptors are the 
targets of many therapeutically important drugs in diseases such as cardiovascular 
disorders (Guimaraes and Moura, 2001), hypertension (Chen et al., 2007) and renal 
failure (Khan et al., 2007). There are two major classes of adrenoceptors; α and β 
adrenoceptors. α-adrenoceptors are further divided into α1 and α2 whereas β 
adrenoceptors are divided into β1, β2 and β3. Furthermore, α1-adrenoceptors are 
subdivided into three subtypes: α1A, α1B, and α1D. α2–adrenoceptors are also classified 
as α2A, α2B, and α2C subtypes (Gilsbach and Hein, 2012; Guimaraes and Moura, 2001). 
Specific actions of the α1 receptors mostly involve smooth muscle contraction. The 
action of α1-adrenoreceptor causes vasoconstriction in most of the blood vessels, 
such as those of the skin (Kenney et al., 1991), renal artery (Schmitz et al., 1981) and 
brain (Young and Kuhar, 1980). The α1-adrenoreceptors mediate renal 
vasoconstriction in rats with hypertension induced by various methods including 
DOCA-salt and two-kidney one clip models of hypertension (Sattar and Johns, 1996). 
Specific actions of the α2–adrenoreceptor include inhibition of insulin release from 
the pancreas (Nakaki et al., 1981), induction of glucagon release from the pancreas 
(Hirose et al., 1992) and negative feedback in the neuronal synapses via presynaptic 
inhibition of noradrenaline (NA) release in central nervous system (Dennis et al., 
1987). The β-adrenoceptors mostly perform inhibitory properties except in the heart. 
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1.4.2 Renal α-adrenergic mechanism 
Renal α1-adrenoceptors mediate the regulation of various renal functions 
including renal hemodynamic, glomerular ultrafiltration, renovascular tone and 
tubular electrolyte reabsorption thereby contributing to the regulation of extracellular 
fluid volume and arterial blood pressure (Dibona and Kopp, 1997). Excessive dietary 
sodium leads to primary hypertension only in those individuals with heightened 
sodium sensitivity associated with a strong genetic background (Chen et al., 2007). 
In hypertension, the primary defect is located in the kidneys. The renal sympathetic 
nerve which densely innervates all the components of the kidney mediates its actions 
through renal α- and β-adrenoceptors during the early stages of the hypertension. 
Renal α-adrenoreceptors are mostly located in proximal tubules and enhance Na+ 
reabsorption. An increased sodium intake affects the expression of the renal 
adrenergic system in normotensive and few hypertensive animal models, which 
contributes to the pathogenesis of hypertension (Tanoue et al., 2002). Previous 
findings have shown that high sodium diets can cause an elevation of renal 
adrenoceptor density (Saiz et al., 1987). High sodium intake associated with 
increased renal adrenoceptor density causes smooth muscle contractility and sodium 
reabsorption resulting in enhancement of renal vasocontraction and sodium retention 
(Weinberger, 1996). These actions result in blood pressure to increase. This increase 
in blood pressure in turn might cause renal injury.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
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1.5 Hypertension 
1.5.1 Definition 
Hypertension is defined as mean systolic blood pressure ≥140 mmHg and 
mean diastolic blood pressure ≥90 mmHg (Chobanian et al., 2003; Mancia et al., 
2013). Hypertension is a major public health issue and its prevalence is high in many 
developing countries as well as in the developed world. The prevalence of 
hypertension in Malaysia remains common and high (Ramli et al., 2012; Rampal et 
al., 2008). Hypertension is a major risk factor for a variety of problems especially 
cardiovascular problems (Krause et al., 2011; Levy et al., 1996). Furthermore, 
hypertension is a cause of chronic kidney disease (Foley et al., 1996). The 
development of unmanaged hypertension leads to mortality among the population. 
Drug treatment, dietary and lifestyle changes can improve blood pressure 
management and lower the risk of hypertension complications. Normal blood 
pressure is within the range of 120-129 mmHg systolic and 80-84 mmHg diastolic. 
High normal blood pressure is within the range of 130-139 mmHg systolic and 85-89 
mmHg diastolic (Mancia et al., 2013). High blood pressure is known as stage 1 
hypertension if it is within the range of 140-159 mmHg systolic and 90-99 mmHg 
diastolic (Burt et al., 1995; Mancia et al., 2013). On the other hand, stage 2 
hypertension occurs when systolic blood pressure exceeds 160 mmHg and diastolic 
blood pressure over 100 mmHg (Burt et al., 1995; Mancia et al., 2013). 
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1.5.2 Types of hypertension 
Hypertension can be classified into essential hypertension and secondary 
hypertension. The essential hypertension is developed by no obvious underlying 
medical causes (Carretero and Oparil, 2000). However, the secondary hypertension is 
caused by other conditions such as increasing age with coexisting atherosclerosis 
(Anderson et al., 1994). There are many interrelated factors that can cause 
hypertension and they vary among different individuals. High sodium intake is one 
of the factors, other factors like obesity, insulin resistance, impaired renin-
angiotensin system and sympathetic nervous system, genetic disorders, endothelial 
dysfunction and neurovascular anomalies can also cause hypertension (Beevers et al., 
2001b). Cardiac output, peripheral resistance, renin-angiotensin-aldosterone system, 
autonomic nervous system, bradykinin, endothelin and nitric oxide (NO) play a role 
in the development of essential hypertension (Zhu et al., 2004). The pathophysiology 
of hypertension is still much unknown (Beevers et al., 2001b). ROS has been 
suggested to impair endothelium-dependent vasodilation and reduce NO production 
during elevated sodium intake (Zhu et al., 2004). In DOCA-salt treated animals, the 
mechanism of induction of endocrine hypertension is due to retention of sodium and 
water, this increases circulating blood volume and results in hypertension. Renin 
angiotensin system is suppressed in DOCA salt hypertension model and treatment 
with AT1-receptor antagonist has no effect on the blood pressure. Normal kidney has 
the physiologic ability to excrete the daily sodium load effectively without allowing 
a significant rise in the extracellular volume. Chronic administration of excess 
sodium can lead to the production of hypertension in rats, which is a good research 
model to mimic hypertension in human subject. 
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1.5.3 Renin-angiotensin-aldosterone system 
Renin-angiotensin-aldosterone system (RAAS) plays an important role in 
long-term maintenance of arterial blood pressure despite extremes in dietary sodium 
intake. Blood pressure is regulated by sodium excretion (Stolarz-Skrzypek et al., 
2011). The release of renin is stimulated when sodium intake is low. Renin release is 
inhibited when sodium intake is high. When the RAAS is dysregulated, changes in 
sodium intake affect the blood pressure (Weir and Dzau, 1999). Furthermore, 
hypertension in response to high sodium intake could be partially due to the result of 
insufficient renal vasodilation which is attributed by RAAS blockade (van Paassen et 
al., 1996). 
 
Renin is secreted from the juxtaglomerular apparatus of the kidney in 
response to glomerular underperfusion or a condition when the sodium intake is 
reduced. Renin is responsible for converting renin substrate (angiotensinogen) to 
Ang I, which is a physiologically inactive substance and is rapidly converted to Ang 
II in the lungs by angiotensin converting enzyme (ACE). Ang II is a potent 
vasoconstrictor and thus causes a rise in blood pressure. It stimulates the release of 
aldosterone which results in a further rise in blood pressure related to sodium and 
water retention (Beevers et al., 2001a). Nevertheless, previous studies have reported 
local participation of the RAAS in cardia vascular system and kidney during sodium 
loading (Navar et al., 2006; Nickenig et al., 1998). This suggested that despite of 
suppressed RAAS with salt loading, cardiac and RAAS could be locally stimulated 
to generate Ang II (Matavelli et al., 2007; Varagic, 2006). 
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1.5.4 Sympathetic nervous system 
The nervous system consists of the central nervous system (CNS); brain and 
spinal cord as well as peripheral nervous system (PNS) (Nieuwenhuys et al., 2007). 
The PNS is divided into sensory (afferent) division and motor (efferent) division. 
The afferent division conveys impulses to the CNS whereas efferent division brings 
impulses out from the CNS to peripheral organs for taking action (Levine et al., 
1986). In PNS, the efferent division is subdivided into somatic nervous system (SNS) 
and autonomic nervous system (ANS). The SNS regulates skeletal muscles for body 
movement (Nurmikko et al., 1991) while the ANS controls heart rate and urination 
(De Groat, 1975; Gabella, 2001; Sztajzel, 2004). The ANS is composed of 
sympathetic division and parasympathetic division (Mathias and Bannister, 2013). 
 
The general action of the sympathetic nervous division is to mobilize the 
function of internal organs as diverse as pupil diameter (Wilhelm et al., 2001), gut 
motility (Straub et al., 2006) and urinary output (Schlaich et al., 2010). It is known 
for mediating the neuronal and hormonal stress response commonly called the fight-
or-flight response and is immediatetly active at a basic level to maintain homeostasis 
(Jansen et al., 1995). The parasympathetic system controls the function of organs and 
glands in the body (Quigley, 2010).  
 
A high sodium intake increases the activity of the sympathetic nervous 
system (Carlson et al., 2000). Moreover, salt sensitivity in essential hypertension has 
been associated with increased sympathetic activity which is supported by increased 
renal sympathetic nerve activity (Campese, 1994). The renal sympathetic nerve plays 
an important part in the modulation of renal function which in turn can affect renin 
 23 
 
release, extracellular fluid volume and blood pressure (Katholi, 1983).  
 
The sympathetic nervous system plays an important role in controlling 
arterial pressure under different conditions by modifying cardiac output, peripheral 
vascular resistance and renal functions. Kidney increases tubular sodium 
reabsorption, renin release and renal vascular resistance when its sympathetic nerves 
are activated (Grisk and Rettig, 2004). 
 
Any disturbed renal sympathetic nerve activity could directly affect the 
kidney. A mishandling of sodium and water, decreased filtration rate and decreased 
glomerular renal blood flows can lead to renal vasoconstriction and substantial renin 
production (Dibona and Kopp, 1997). Ang II activates NADH/NADPH oxidase that 
increases O2
−
 in vascular tissues (Campese et al., 2005). Previous reports have 
documented that ROS could also mediate the effects of Ang II on sympathtic nerve 
activity (Ye et al., 2006) and elevation of O2
−
 can decrease sodium excretion thus 
leading to hypertension.  
 
Abnormal increase in the renal sympathetic nerve activity in hypertension can 
alter renal function. The changing of sodium and water retention will increase blood 
volume. An increased blood volume associated with an elevated arterial blood 
pressure enhance urinary sodium excretion and water excretion in order to maintain 
homeostasis (DiBona, 2004). 
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High sodium intake activates the central sympathoecitatory mechanisms by 
increasing brain angiotensin activity and sodium concentration in cerebrospinal fluid 
(Huang and Leenen, 1998). The increased Ang II in brain due to  high sodium intake 
can alter the brain in regulating renal sympathetic nerve activity and renal excretory 
function (Johns, 2002). 
 
The arterial baroreceptor reflex activity can modulate the arterial pressure and 
sodium homeostasis through the renal sympathetic nerve system (Osborn and 
Hornfeldt, 1998). An increased mean arterial pressure due to high sodium intake can 
stimulate the sensitivity of arterial baroreceptor. The stimulation can lead to heart 
relaxation, peripheral blood vessels dilation and reduced stimulation on kidney. 
These actions reduce renal tubular sodium reabsorption and produce natriuresis, 
which normalize the arterial pressure (Guyton et al., 1972). 
 
1.6 Oxidative stress  
Oxidative stress is an imbalance between oxidants and antioxidants in favour 
of the oxidants which potentially leads to damage (Sies, 1997). Oxidative stress can 
cause toxic effects through the production of peroxides and free radicals that damage 
cells. Oxidative stress plays a role in many clinical conditions such as hypertension, 
diabetes, and renal failure (Banday et al., 2007; Dobrian et al., 2003; Maritim et al., 
2003; Massy and Nguyen-Khoa, 2001). 
 
 
